Patient Monitoring & Vital Signs in New Jersey

Therakos LLC manufactures the THERAKOS® CELLEX® Photopheresis System, an FDA-approved extracorporeal photopheresis (ECP) device for the palliative treatment of skin manifestations of cutaneous T-cell lymphoma (CTCL) unresponsive to other therapies. The system performs ultraviolet-A (UVA) irradiation of leukocyte-enriched blood in the presence of 8-methoxypsoralen (8-MOP), with co-administered pharmaceutical UVADEX® (methoxsalen) sterile solution. The company provides a complete therapeutic platform including the photopheresis system hardware, consumables, operator training through the Therakos Institute, and comprehensive customer support services branded as Therakos Total Care. The system is designed for use in clinical settings where standard medical emergency equipment and volume management capability are available. Following acquisition by CVC, certain operations continue under transition services agreement with Mallinckrodt Pharmaceuticals. Therakos markets primarily to hematology-oncology centers, dermatology departments, and specialized treatment centers managing CTCL patients. The company maintains dedicated business manager support and professional education programs for treating physicians and clinical staff. Product indications and contraindications are clearly defined with specific patient selection criteria and comprehensive safety protocols documented in the operator's manual and UVADEX prescribing information.

Mirion Technologies is a global provider of radiation detection, measurement, and safety solutions serving nuclear power operations, medical imaging and cancer care, occupational dosimetry, and environmental radiochemistry. The company specializes in radiological instrumentation, personal and area dosimetry products, radiation survey monitoring equipment, and supervisory software platforms. Key product lines include the Vital® Supervision platform (centralized radiological instrumentation management), CSPevo® Probe Family (portable radiation survey monitoring), Instadose®VUE (wireless personal dosimeters), and FRAM isotopic analysis systems. Mirion serves nuclear utilities, medical oncology centers, radiopharmaceutical manufacturers, research institutions (including the IAEA), and government agencies including NASA. The company provides training courses in radiation measurement and equipment operation, hosts industry conferences (Mirion Connect), and maintains service and support capabilities across multiple markets. Recent acquisitions and partnerships (Paragon Energy Solutions, Certrec) expand capabilities in nuclear licensing and infrastructure. Mirion's dosimetry products are used by healthcare workers and space program personnel (NASA Artemis missions).

EUROIMMUN US, a subsidiary of the global leader EUROIMMUN Medizinische Labordiagnostika AG, is a manufacturer of in vitro diagnostic reagents and automation systems for clinical laboratory testing. The company specializes in immunodiagnostic assays and automated laboratory analyzers serving clinical laboratories, reference laboratories, and hospital laboratories across North America. Core product portfolios include autoimmune disease diagnostics, infectious disease serology (including viral serology for Zika, COVID-19, Oropouche, and other pathogens), allergy testing, endocrinology assays, bone metabolism markers, neurodegeneration biomarkers, and therapeutic drug monitoring. The company manufactures the IDS i20 random access chemiluminescent analyzer, AP2400 automated T-SPOT.TB testing system (FDA-approved), and distributes the ProciseDx platform. EUROIMMUN US offers training and education through its Academy and Pattern IQ learning platform for ANA pattern recognition. The company provides field service and technical support to laboratory customers. Products are designed for CLIA-certified clinical laboratories and diagnostic reference centers. The company is now part of the Revvity organization.